Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06393751
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2024-04-30
Brief Title:
Testing the Addition of ASTX660 Tolinapant to the Usual Chemotherapy Treatment Paclitaxel With or Without Bevacizumab in Patients With Recurrent Ovarian Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-02-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-09
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-30
First Submit QC Date:
April 30 2024
Study First Post Date:
2024-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-02
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL